{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:20:46Z","timestamp":1772065246323,"version":"3.50.1"},"reference-count":45,"publisher":"American Association for Cancer Research (AACR)","issue":"6","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The phosphatidylinositol 3-kinase (PI3K) pathway regulates various cellular processes, including cellular proliferation and intracellular trafficking, and may affect prostate carcinogenesis. Thus, we explored the association between single-nucleotide polymorphisms (SNP) in PI3K genes and prostate cancer. Pooled data from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium were examined for associations between 89 SNPs in PI3K genes (PIK3C2B, PIK3AP1, PIK3C2A, PIK3CD, and PIK3R3) and prostate cancer risk in 8,309 cases and 9,286 controls. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated using logistic regression. SNP rs7556371 in PIK3C2B was significantly associated with prostate cancer risk [ORper allele, 1.08 (95% CI, 1.03\u20131.14); Ptrend = 0.0017] after adjustment for multiple testing (Padj = 0.024). Simultaneous adjustment of rs7556371 for nearby SNPs strengthened the association [ORper allele, 1.21 (95% CI, 1.09\u20131.34); Ptrend = 0.0003]. The adjusted association was stronger for men who were diagnosed before the age of 65 years [ORper allele, 1.47 (95% CI, 1.20\u20131.79); Ptrend = 0.0001] or had a family history [ORper allele = 1.57 (95% CI, 1.11\u20132.23); Ptrend = 0.0114], and was strongest in those with both characteristics [ORper allele = 2.31 (95% CI, 1.07\u20135.07), P-interaction = 0.005]. Increased risks were observed among men in the top tertile of circulating insulin-like growth factor-I (IGF-I) levels [ORper allele = 1.46 (95% CI, 1.04\u20132.06); Ptrend = 0.075]. No differences were observed with disease aggressiveness (Gleason grade \u22658 or stage T3\/T4 or fatal). In conclusion, we observed a significant association between PIK3C2B and prostate cancer risk, especially for familial, early-onset disease, which may be attributable to IGF-dependent PI3K signaling. Cancer Res; 70(6); 2389\u201396<\/jats:p>","DOI":"10.1158\/0008-5472.can-09-3575","type":"journal-article","created":{"date-parts":[[2010,3,3]],"date-time":"2010-03-03T03:00:32Z","timestamp":1267585232000},"page":"2389-2396","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Pooled Analysis of Phosphatidylinositol 3-Kinase Pathway Variants and Risk of Prostate Cancer"],"prefix":"10.1158","volume":"70","author":[{"given":"Stella","family":"Koutros","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrick R.","family":"Schumacher","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Hayes","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Yi","family":"Huang","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrius","family":"Albanes","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Canzian","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Chanock","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. David","family":"Crawford","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Ryan","family":"Diver","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather Spencer","family":"Feigelson","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Giovanucci","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Haiman","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian E.","family":"Henderson","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Hunter","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Kaaks","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence N.","family":"Kolonel","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kraft","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\u00efc","family":"Le Marchand","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elio","family":"Riboli","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshan","family":"Siddiq","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mier J.","family":"Stampfer","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel O.","family":"Stram","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Thomas","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth C.","family":"Travis","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Thun","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Yeager","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja I.","family":"Berndt","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2Department of Preventive Medicine, University of Southern California, Los Angeles, California; 3New York University School of Medicine, New York, New York; 4Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 5Harvard School of Public Health, Boston, Massachusetts; 6German Cancer Research Center (DKFZ), Heidelberg, Germany; 7Department of Urology, University of Colorado Health Sciences Center, Aurora, Colorado; 8Department of Epidemiology, American Cancer Society, Atlanta, Georgia; 9Kaiser Permanente, Denver, Colorado; 10Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 11Imperial College, London, United Kingdom; and 12Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2010,3,14]]},"reference":[{"key":"2022061702414536900_bib1","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1242\/jcs.00609","article-title":"The phosphoinositide (PI) 3-kinase family","volume":"116","author":"Foster","year":"2003","journal-title":"J Cell Sci"},{"key":"2022061702414536900_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.67.1.481","article-title":"Phosphoinositide kinases","volume":"67","author":"Fruman","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"2022061702414536900_bib3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/clinchem\/44.4.705","article-title":"Growth factor involvement in progression of prostate cancer","volume":"44","author":"Russell","year":"1998","journal-title":"Clin Chem"},{"key":"2022061702414536900_bib4","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nrd1902","article-title":"Exploiting the PI3K\/AKT pathway for cancer drug discovery","volume":"4","author":"Hennessy","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"2022061702414536900_bib5","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1158\/1055-9965.EPI-06-1062","article-title":"Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition","volume":"16","author":"Allen","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022061702414536900_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study","volume":"279","author":"Chan","year":"1998","journal-title":"Science"},{"key":"2022061702414536900_bib7","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1210\/jc.2007-0790","article-title":"Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population","volume":"92","author":"Cheng","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2022061702414536900_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10552-004-3484-8","article-title":"Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era","volume":"16","author":"Platz","year":"2005","journal-title":"Cancer Causes Control"},{"key":"2022061702414536900_bib9","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1002\/ijc.23787","article-title":"An activating mutation in AKT1 in human prostate cancer","volume":"123","author":"Boormans","year":"2008","journal-title":"Int J Cancer"},{"key":"2022061702414536900_bib10","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"275","author":"Li","year":"1997","journal-title":"Science"},{"key":"2022061702414536900_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-Kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2022061702414536900_bib12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.bjc.6604947","article-title":"Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer","volume":"100","author":"Quaye","year":"2009","journal-title":"Br J Cancer"},{"key":"2022061702414536900_bib13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1158\/1078-0432.CCR-07-1211","article-title":"Association between phosphatidylinositol 3-kinase regulatory subunit p85\u03b1 Met326Ile genetic polymorphism and colon cancer risk","volume":"14","author":"Li","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2022061702414536900_bib14","first-page":"172","article-title":"Association between the Met326Ile polymorphism of the p85\u03b1 regulatory subunit of phosphatidylinositol 3-kinase and prostate cancer risk: a prospective study","volume":"12","author":"Paradis","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022061702414536900_bib15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/1055-9965.EPI-05-0896","article-title":"Common genetic variation at PTEN and risk of sporadic breast and prostate cancer","volume":"15","author":"Haiman","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022061702414536900_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1042\/BJ20081610","article-title":"The TGF-\u03b2, PI3K\/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer","volume":"417","author":"Assinder","year":"2009","journal-title":"Biochem J"},{"key":"2022061702414536900_bib17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1055-9965.EPI-06-0895","article-title":"Lack of association of transforming growth factor-\u03b21 polymorphisms and haplotypes with prostate cancer risk in the prostate, lung, colorectal, and ovarian trial","volume":"16","author":"Kang","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022061702414536900_bib18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrc1754","article-title":"A candidate gene approach to searching for low-penetrance breast and prostate cancer genes","volume":"5","author":"Hunter","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"2022061702414536900_bib19","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/jnci\/94.14.1099","article-title":"Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer","volume":"94","author":"Chan","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"2022061702414536900_bib20","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/ijc.22921","article-title":"IGF-1 and IGFBP-3: risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial","volume":"121","author":"Weiss","year":"2007","journal-title":"Int J Cancer"},{"key":"2022061702414536900_bib21","first-page":"3991","article-title":"Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men","volume":"63","author":"Woodson","year":"2003","journal-title":"Cancer Res"},{"key":"2022061702414536900_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/381000","article-title":"Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium","volume":"74","author":"Carlson","year":"2004","journal-title":"Am J Hum Genet"},{"key":"2022061702414536900_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.genom.9.081307.164242","article-title":"Genotype imputation","volume":"10","author":"Li","year":"2009","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2022061702414536900_bib24","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ng1899","article-title":"Transferability of tag SNPs in genetic association studies in multiple populations","volume":"38","author":"de Bakker","year":"2006","journal-title":"Nat Genet"},{"key":"2022061702414536900_bib25","first-page":"921","article-title":"Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population","volume":"12","author":"Excoffier","year":"1995","journal-title":"Mol Biol Evol"},{"key":"2022061702414536900_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1086\/338688","article-title":"Score tests for association between traits and haplotypes when linkage phase is ambiguous","volume":"70","author":"Schaid","year":"2002","journal-title":"Am J Hum Genet"},{"key":"2022061702414536900_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000071811","article-title":"Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous","volume":"55","author":"Lake","year":"2003","journal-title":"Hum Hered"},{"key":"2022061702414536900_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/gepi.20310","article-title":"A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms","volume":"32","author":"Gao","year":"2008","journal-title":"Genet Epidemiol"},{"key":"2022061702414536900_bib29","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1091\/mbc.e05-11-1083","article-title":"Phosphoinositide 3-Kinase C2\u03b2 regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms","volume":"17","author":"Katso","year":"2006","journal-title":"Mol Biol Cell"},{"key":"2022061702414536900_bib30","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1083\/jcb.200408005","article-title":"Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration","volume":"169","author":"Maffucci","year":"2005","journal-title":"J Cell Biol"},{"key":"2022061702414536900_bib31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1042\/bj3330471","article-title":"Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling","volume":"333","author":"Shepherd","year":"1998","journal-title":"Biochem J"},{"key":"2022061702414536900_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/bst0290535","article-title":"Growth factor regulation of the novel class II phosphoinositide 3-kinases","volume":"29","author":"Brown","year":"2001","journal-title":"Biochem Soc Trans"},{"key":"2022061702414536900_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.critrevonc.2005.10.003","article-title":"Insulin-like growth factor (IGF) family and prostate cancer","volume":"58","author":"Gennigens","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"2022061702414536900_bib34","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/ijc.24202","article-title":"Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis","volume":"124","author":"Rowlands","year":"2009","journal-title":"Int J Cancer"},{"key":"2022061702414536900_bib35","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"2022061702414536900_bib36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/cncr.22443","article-title":"Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality","volume":"109","author":"Wright","year":"2007","journal-title":"Cancer"},{"key":"2022061702414536900_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1158\/1055-9965.EPI-06-0754","article-title":"Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort","volume":"16","author":"Rodriguez","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022061702414536900_bib38","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10552-006-0049-z","article-title":"Body size and composition and prostate cancer risk: systematic review and meta-regression analysis","volume":"17","author":"MacInnis","year":"2006","journal-title":"Cancer Causes Control"},{"key":"2022061702414536900_bib39","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.2741\/3402","article-title":"MDM2 and MDM4 splicing: an integral part of the cancer spliceome","volume":"14","author":"Jeyaraj","year":"2009","journal-title":"Front Biosci"},{"key":"2022061702414536900_bib40","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/ng2109","article-title":"A genome-wide association study of global gene expression","volume":"39","author":"Dixon","year":"2007","journal-title":"Nat Genet"},{"key":"2022061702414536900_bib41","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.1997.03550150055035","article-title":"Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus","volume":"278","author":"Gronberg","year":"1997","journal-title":"JAMA"},{"key":"2022061702414536900_bib42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/sj.pcan.4500257","article-title":"Does a family history of prostate cancer result in more aggressive disease?","volume":"1","author":"Klein","year":"1998","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2022061702414536900_bib43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00001648-199711000-00011","article-title":"Family history and risk of fatal prostate cancer","volume":"8","author":"Rodriguez","year":"1997","journal-title":"Epidemiology"},{"key":"2022061702414536900_bib44","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1158\/1078-0432.CCR-08-2190","article-title":"Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features","volume":"15","author":"Fitzgerald","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2022061702414536900_bib45","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00439-006-0219-9","article-title":"Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics","volume":"120","author":"Schaid","year":"2006","journal-title":"Hum Genet"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/6\/2389\/2645288\/2389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/6\/2389\/2645288\/2389.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T10:19:28Z","timestamp":1655461168000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/70\/6\/2389\/561268\/Pooled-Analysis-of-Phosphatidylinositol-3-Kinase"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,14]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2010,3,14]]},"published-print":{"date-parts":[[2010,3,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-09-3575","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,14]]}}}